Related Experiment Videos
Penile cancer: organ-sparing surgery
Antonio Carlos Lima Pompeo1, Stênio de Cássio Zequi, Alexandre Saad Feres Lima Pompeo
1aDepartment of Urology ABC Medical School, Santo André bDivision of Urology, Department of Pelvic Surgery, AC Camargo Cancer Center cDivision of Urology, ABC Medical School, Santo André, São Paulo, Brasil.
Current Opinion in Urology
|January 20, 2015
Summary
Penile-sparing surgeries (PSSs) offer a viable alternative for superficial penile cancers (Tis, Ta-1, selected T2), preserving function and body image. Careful patient selection and follow-up are crucial for managing slightly higher recurrence rates compared to amputation.
Area of Science:
- Oncology
- Urology
- Surgical Oncology
Background:
- Penile cancer often leads to disfiguring surgeries impacting quality of life.
- Penile-sparing surgeries (PSSs) are gaining traction to mitigate these effects.
Purpose of the Study:
- To review the current landscape of penile-sparing surgeries for penile cancer.
- To evaluate the efficacy and indications for PSS in penile cancer management.
Main Methods:
- Review of current literature on penile-sparing surgical techniques.
- Analysis of oncological control, functional outcomes, and cosmetic results of PSS.
- Evaluation of recurrence rates and salvage options.
Main Results:
- Various PSS options exist for superficial penile cancers (Tis, Ta-1, selected T2), including local excision, glansectomies, and reconstructions.
- These techniques generally provide good local control, functional, and cosmetic outcomes.
- Local recurrence rates may be slightly higher than with amputation, necessitating vigilant follow-up.
Conclusions:
- PSS is indicated for superficial penile cancers (Tis, Ta-1) and select invasive tumors (small distal pT2).
- Patient adherence to follow-up is essential for early detection of recurrences.
- Prompt salvage procedures are critical for patients undergoing PSS.